Host defense, viruses and apoptosis

Cell Death and Differentiation

Volumn 8, Issue 2, 2001, Pages 113-126

  Barber, G N ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Immunity; Virus

Indexed keywords

CYTOKINE; DOUBLE STRANDED RNA; GRANZYME A; GRANZYME B; INTERFERON; INTERFERON REGULATORY FACTOR 3; PERFORIN; PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS DNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL DEATH; CELL INVASION; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DNA DETERMINATION; GENETIC ANALYSIS; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION CONTROL; MEDIATOR RELEASE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; VIRAL GENETICS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADENINE NUCLEOTIDES; ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; EIF-2 KINASE; ENDORIBONUCLEASES; GENES, REGULATOR; HUMANS; INTERFERONS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; OLIGORIBONUCLEOTIDES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; VIRUS DISEASES; VIRUSES;

ANIMALIA; DNA VIRUSES;

EID: 0035094982     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400823     Document Type: Review

References (156)

1. Initial and innate responses to viral infections-pattern setting in immunity or disease
2. Control of early viral and bacterial distribution and disease by natural antibodies
3. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
4. How to induce involuntary suicide: The need for dipeptidyl peptidase I
5. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
6. Cell suicide for beginners
7. Genetic control of programmed cell death in the nematode Caenorhabditis elegans
8. Programmed cell death and the caspases
9. Lymphocyte granule-mediated apoptosis: Matters of viral mimicry and deadly proteases
10. Death receptors: Signaling and modulation
11. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
12. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
13. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
14. Modulation of life and death by the TNF receptor superfamily
15. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
16. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death
17. IAP family proteins-suppressors of apoptosis
18. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation
19. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
20. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation
21. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
22. Role of NF-kappaB in p53-mediated programmed cell death
23. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes
24. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
25. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
26. Mitochondria and apoptosis
27. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
28. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
29. Molecular characterization of mitochondrial apoptosis-inducing factor
30. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
31. The Bcl-2 protein family: Arbiters of cell survival
32. Virus-induced apoptosis
33. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak
34. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death
35. Viruses and apoptosis
36. Inhibition of virus-induced neuronal apoptosis by Bax
37. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
38. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
39. The nature of the principal type 1 interferon-producing cells in human blood
40. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
41. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
42. Functional role of type I and type II interferons in antiviral defense
43. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
44. Virus Interference: The interferons
45. How cells respond to interferons
46. JNK2 and IKKbeta are required for activating the innate response to viral infection
47. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kappaB
48. Deficient signaling in mice devoid of double-stranded-RNA-dependent protein kinase
49. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
50. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway
51. The molecular basis for responsiveness to anti-viral therapy in hepatitis C
52. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid
53. Specificity of interferon-induced enhancement of toxicity for double-stranded ribonucleic acids
54. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
55. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling
56. Type I interferons are essential mediators of apoptotic death in virally infected cells
57. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
58. Double-stranded RNA and interferon action
59. The 2-5A system: A personal view
60. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1
61. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth
62. Triggering the interferon response: The role of IRF-3 transcription factor
63. The growing family of interferon regulatory factors
64. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation
65. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo
66. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
67. Regulation of type I interferon gene expression by interferon regulatory factor-3
68. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis
69. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
70. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen- activated T lymphocytes
71. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1}
72. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes
73. Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein
74. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
75. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation
76. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis
77. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases
78. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
79. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity
80. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection
81. Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic
82. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
83. Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB
84. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction
85. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53
86. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways
87. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR
88. How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
89. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2
90. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase
91. Malignant transformation by a mutant of the IFN-inducible dsRNA- dependent protein kinase
92. Tumor suppressor function of the interferon-induced double-stranded-RNA-activated protein kinase
93. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis
94. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection
95. An essential role for the interferon-inducible, double-stranded RNA- activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells
96. PKR; a sentinel kinase for cellular stress
97. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
98. PKR, apoptosis and cancer
99. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase
100. The elF-2 alpha kinases: Regulators of protein synthesis in starvation and stress
101. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
102. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis
103. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action
104. The human 2′,5′-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties
105. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells
106. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L
107. Type 1 interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
108. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
109. The TRAIL to selective tumor death
110. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
111. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells
112. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death
113. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
114. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML)
115. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
116. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
117. PML induces a novel caspase-independent death process
118. PML is essential for multiple apoptotic pathways
119. p53 and apoptosis
120. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
121. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
122. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
123. Regulation of apoptosis by viral gene products
124. p53 inhibition by the LANA protein of KSHV protects against cell death
125. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins
126. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
127. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
128. Regulation of the interferon-induced PKR: Can viruses cope?
129. The elF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans
130. Structure, function, and evolution of adenovirus virus-associated RNAs
131. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells
132. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
133. Viral interference with apoptosis
134. Apoptosis in HIV infection
135. AIDS and the death receptors
136. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by upregulating FLICE/caspase-8
137. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells
138. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines
139. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha
140. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus- associated lymphomas
141. AIDS-associated malignancies: Research perspectives
142. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine
143. Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma
144. The mechanism of IFN targeted therapy against HHV-8 associated lymphoma involves the induction of TRAIL-mediated apoptosis
145. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease
146. Recent developments in the virus therapy of cancer
147. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases
148. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
149. Vesicular stomatitis virus therapy of tumors
150. Reovirus therapy of tumors with activated Ras pathway
151. Replicative adenoviruses for cancer therapy
152. Type I interferons keep activated T cells alive
153. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis
154. The oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras or Myc function and involves the induction of apoptosis